New Delhi [India], January 5 (ANI): The Subject Experts Committee (SEC) of the Drug Controller General of India (DCGI) on Wednesday granted approval to Bharat Biotech for conducting intranasal phase 3 trials and heterologous trials for COVID-19 booster intranasal vaccine for those who hav
New Delhi [India], January 4 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is expected to meet on Tuesday afternoon to discuss Bharat Biotech's application for clinical trials of its intranasal Covid vaccine as a booster or a third dose.
Washington [US], January 2 (ANI): A new study evaluated the clinical characteristics and outcomes of fully vaccinated patients with cancer who had breakthrough COVID-19 infections indicating that they remained at high risk for hospitalization and death.
Texas [US], December 31 (ANI): A study has found strong evidence that the current trial-and-error approach used in clinical practice for the selection of the right antidepressant can be replaced with this new precision medicine approach.
Hyderabad (Telangana) [India], December 30 (ANI): Hyderabad based vaccine manufacturer Bharat Biotech on Thursday announced that Covaxin (BBV152) has been found to be "safe, well-tolerated, and immunogenic" in the age group of 2-18 years in phase II/III study, said a company's statement.
Sarajevo [Bosnia], December 29 (ANI/Sputnik): The Omicron strain of coronavirus has been registered in ten patients in Bosnia and Herzegovina, Sebija Izetbegovic, director of the Clinical Center of the University of Sarajevo, said on Wednesday.
New Delhi [India], December 29 (ANI): The Drug Controller General of India (DCGI) has given approval to the Hyderbad-based pharmaceutical company Biological E to conduct phase 3 clinical trials of its COVID-19 vaccine Corbevax as a booster dose, said sources.
Hyderabad (Telangana) [India], December 28 (ANI/PNN): Hyderabad, Optimus Pharma announced launching of their front line COVID-19 medication Molnupiravir in the Indian market, as they have received permission the restricted emergency use for Covid-19 drug.
New Delhi [India], December 23 (ANI): Centre propose a fivefold strategy for tackling the threat of COVID-19 variant 'Omicron', in a review meeting on Thursday over public health preparedness by States and Union Territories for fighting COVID19 and the Omicron variant.
New Delhi [India], December 20 (ANI): As India is witnessing a surge in cases of "highly transmissible" Omicron variant, Hyderabad-based Bharat Biotech has submitted the phase 3 clinical trial application to the Drugs Controller General of India (DCGI) to get approval for the booster dose
Dhaka [Bangladesh], December 18 (ANI): Indian hockey team came up with a clinical performance against arch-rival Pakistan to register a resounding 3-1 win in the league stage match of the Asian Champions Trophy 2021 in Dhaka. India's star performer was drag-flicker Harmanpreet Singh who conv
Geneva [Switzerland], December 14 (ANI): The World Health Organization (WHO) has said that it expects an increase in the number of hospitalisations and fatalities related to the new Omicron coronavirus strain, reported Sputnik.